# Paired-Comparison Study Evaluating the Efficacy and Safety of E6201 Versus Vehicle for the Treatment of Plaque-Type Psoriasis

> **NCT00539929** · PHASE2 · COMPLETED · sponsor: **Eisai Inc.** · enrollment: 100 (actual)

## Conditions studied

- Chronic Plaque Psoriasis

## Interventions

- **DRUG:** E6201 0.005%
- **DRUG:** E6201 0.01%
- **DRUG:** E6201 0.03%
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00539929
- **Lead sponsor:** Eisai Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2008-06
- **Final completion:** 2008-07
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2017-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00539929

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00539929, "Paired-Comparison Study Evaluating the Efficacy and Safety of E6201 Versus Vehicle for the Treatment of Plaque-Type Psoriasis". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00539929. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*